BC Week In Review | Jul 11, 2016
Financial News

Guided Therapeutics proposes private placement of convertible preferred stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date announced: 2016-07-01   Type: Private placement of convertible preferred stock and warrants   To be raised: Up to $5 million   Shares: 5,000  ...
BC Week In Review | Jun 13, 2016
Company News

Guided Therapeutics, Shenguo Medical deal

Guided Therapeutics granted Shenghuo exclusive rights to manufacture and commercialize LuViva Advanced Cervical Scan and associated disposable products in China, Taiwan, Brunei, Cambodia, Laos, Myanmar, Philippines, Thailand, Vietnam and Singapore. Guided Therapeutics will issue a...
BC Week In Review | Sep 28, 2015
Financial News

Guided Therapeutics completes private placement of convertible preferred stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date completed: 2015-09-03   Type: Private placement of convertible preferred stock and warrants   Raised: $1.3 million   Shares: 1,734   Price: $750   Shares...
BC Week In Review | Jul 20, 2015
Financial News

Guided Therapeutics completes

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date completed: 2015-06-30   Raised: $2.5 million   Shares: 3,334   Price: $750   Shares outstanding prior: 113.7 million   Placement agent: Ladenburg Thalmann  ...
BC Week In Review | Jun 1, 2015
Clinical News

LuViva Advanced Cervical Scan regulatory update

FDA said Guided Therapeutics’ PMA amendment for LuViva Advanced Cervical Scan non-invasive cervical cancer test was not approvable and said more patient data would be necessary. According to the company, FDA said it was willing...
BC Week In Review | Apr 20, 2015
Financial News

Guided Therapeutics completes private placement of common stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date completed: 2015-04-15   Type: Private placement of common stock and warrants   Raised: $720,000   Shares: 4 million   Price: $0.18   Shares after...
BC Week In Review | Sep 22, 2014
Financial News

Guided Therapeutics proposes private placement of common stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date announced: 2014-09-08   Type: Private placement of common stock and warrants   To be raised: $200,000   Shares: 651,042   Price: $0.31   Shares...
BC Week In Review | Sep 8, 2014
Clinical News

LuViva Advanced Cervical Scan: Postmarketing study started

Guided Therapeutics began a blinded, U.S. and Peruvian postmarketing trial to compare LuViva Advanced Cervical Scan vs. visual examination with acetic acid, cytology, HPV, colposcopy and biopsy in 600-800 women. LuViva is approved in the...
BC Week In Review | Jun 2, 2014
Financial News

Guided Therapeutics completes private placement of senior convertible notes

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date completed: 5/23/14   Type: Private placement of senior convertible notes   Raised: $2 million   Placement agent: Olympus Securities   Shares outstanding prior: 72.2...
BC Week In Review | May 5, 2014
Financial News

Guided Therapeutics completes private placement of senior convertible notes

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date completed: 4/23/14   Type: Private placement of senior convertible notes   Raised: $1 million   Placement agent: Etico Capital   Shares outstanding prior: 72.2...
Items per page:
1 - 10 of 116
BC Week In Review | Jul 11, 2016
Financial News

Guided Therapeutics proposes private placement of convertible preferred stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date announced: 2016-07-01   Type: Private placement of convertible preferred stock and warrants   To be raised: Up to $5 million   Shares: 5,000  ...
BC Week In Review | Jun 13, 2016
Company News

Guided Therapeutics, Shenguo Medical deal

Guided Therapeutics granted Shenghuo exclusive rights to manufacture and commercialize LuViva Advanced Cervical Scan and associated disposable products in China, Taiwan, Brunei, Cambodia, Laos, Myanmar, Philippines, Thailand, Vietnam and Singapore. Guided Therapeutics will issue a...
BC Week In Review | Sep 28, 2015
Financial News

Guided Therapeutics completes private placement of convertible preferred stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date completed: 2015-09-03   Type: Private placement of convertible preferred stock and warrants   Raised: $1.3 million   Shares: 1,734   Price: $750   Shares...
BC Week In Review | Jul 20, 2015
Financial News

Guided Therapeutics completes

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date completed: 2015-06-30   Raised: $2.5 million   Shares: 3,334   Price: $750   Shares outstanding prior: 113.7 million   Placement agent: Ladenburg Thalmann  ...
BC Week In Review | Jun 1, 2015
Clinical News

LuViva Advanced Cervical Scan regulatory update

FDA said Guided Therapeutics’ PMA amendment for LuViva Advanced Cervical Scan non-invasive cervical cancer test was not approvable and said more patient data would be necessary. According to the company, FDA said it was willing...
BC Week In Review | Apr 20, 2015
Financial News

Guided Therapeutics completes private placement of common stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date completed: 2015-04-15   Type: Private placement of common stock and warrants   Raised: $720,000   Shares: 4 million   Price: $0.18   Shares after...
BC Week In Review | Sep 22, 2014
Financial News

Guided Therapeutics proposes private placement of common stock and warrants

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date announced: 2014-09-08   Type: Private placement of common stock and warrants   To be raised: $200,000   Shares: 651,042   Price: $0.31   Shares...
BC Week In Review | Sep 8, 2014
Clinical News

LuViva Advanced Cervical Scan: Postmarketing study started

Guided Therapeutics began a blinded, U.S. and Peruvian postmarketing trial to compare LuViva Advanced Cervical Scan vs. visual examination with acetic acid, cytology, HPV, colposcopy and biopsy in 600-800 women. LuViva is approved in the...
BC Week In Review | Jun 2, 2014
Financial News

Guided Therapeutics completes private placement of senior convertible notes

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date completed: 5/23/14   Type: Private placement of senior convertible notes   Raised: $2 million   Placement agent: Olympus Securities   Shares outstanding prior: 72.2...
BC Week In Review | May 5, 2014
Financial News

Guided Therapeutics completes private placement of senior convertible notes

Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga.   Business: Diagnostic   Date completed: 4/23/14   Type: Private placement of senior convertible notes   Raised: $1 million   Placement agent: Etico Capital   Shares outstanding prior: 72.2...
Items per page:
1 - 10 of 116